GNAS mutations at locus 201 were found in 66% of intraductal papillary mucinous neoplasms. Investigators claim mutations in a gene known as GNAS can help distinguish between nonmalignant pancreatic ...

An intraductal papillary mucinous neoplasm (IPMN) is a benign or noncancerous cyst in the ducts of the pancreas. The cysts are sometimes precancerous, which means they may lead to pancreatic cancer.

A research team at Duke Health has identified a set of biomarkers that could help to distinguish whether cysts on the pancreas are likely to develop into cancer or remain benign. The team carried out ...

Detection of early-stage pancreatic ductal adenocarcinoma (PDAC): Sensitivity, specificity, and discriminatory properties of the serum-based PAM4-immunoassay. The effect of vascular reconstruction on ...

Researchers have outlined the comprehensive immune landscape and microbiome of pancreatic cysts as they progress from benign cysts to pancreatic cancer. The findings could reveal the mechanism of ...

Increased numbers of small, asymptomatic pancreatic cysts are being detected; however, the optimal management of these lesions is not clear. This retrospective, single-center study included patients ...

Asuragen reports data from a study of microRNA biomarkers in pancreatic cyst fluid at the American Pancreatic Association Annual Meeting Austin, Texas - November 3, 2011. Asuragen, Inc. announced ...

The ever-increasing use of radiographic imaging of the abdomen, in particular by CT and MRI, has led to a significant rise in the discovery of patients with pancreatic cysts. Often these are ...

The study also included measurement of four protein markers present in the cyst fluid. All four proteins were overexpressed in the high-risk versus the low-risk group (P < .001). Adding the findings ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: Are you aware of the possibility of pancreatitis resulting ...

SAN DIEGO--(BUSINESS WIRE)--Biological Dynamics, Inc., a leader in exosome enrichment technology for early disease detection, will present a “lightning talk” as part of the “Understanding Pre-cancers ...